ATOSSA THERAPEUTICS, INC.: cash_and_equivalents

Value{"amount": 9105950, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2020-09-30)
Statuscurrent
EntityATOSSA THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001437749-20-023747 · Open the official SEC filing →
Retrieved: 2026-08-19T14:48:01.895087+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001488039/cash-and-equivalents/2020-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/bf2e2c00-69ee-40d8-8e5b-c14c5b160b9a

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies